AI Article Synopsis

  • LDL-C lowering is essential for preventing atherosclerotic disease progression in post-acute coronary syndrome (ACS) patients, but managing LDL-C remains difficult in clinical settings.
  • The ACS EuroPath III project aimed to enhance LDL-C management by gathering data from healthcare providers and patients through surveys, identifying key improvement areas, and creating actionable solutions for better treatment practices.
  • Five areas needing improvement were pinpointed, including issues with discharge treatment, guideline knowledge, and patient concerns; top solutions proposed included a standardized discharge letter and a treatment algorithm for better LDL-C management.

Article Abstract

Background: Low-density lipoprotein cholesterol (LDL-C) lowering is key to reduce atherosclerotic disease progression and recurrent events for patients after acute coronary syndrome (ACS). However, LDL-C management for post-ACS patients remains challenging in clinical practice.

Hypothesis: The ACS EuroPath III project was designed to optimize LDL-C management in post-ACS patients by promoting guideline implementation and translating existing evidence into effective actions.

Methods: Three surveys targeting cardiologists (n = 555), general practitioners (GPs; n = 445), and patients (n = 662) were conducted in Europe, with the aim of capturing information on patient characteristics and treatment during acute phase, discharge and follow-up. GPs' and patients' opinions on key treatment aspects were also collected. Based on survey results, international experts and clinicians identified areas of improvement and generated prototype solutions. Participants voted to select the most feasible and replicable proposals for co-development and implementation.

Results: Five key areas of improvement were identified: (1) inappropriate treatment prescribed at discharge; (2) lack of lipid guidance in the discharge letter; (3) inadequate lipid-lowering therapy (LLT) optimization; (4) gaps in guideline knowledge and lack of referral practices for GPs; (5) patients' concerns about lipid management. Proposed solutions for these focus areas included development of a treatment algorithm for the acute phase, a standardized GP discharge letter, an assessment tool for LLT efficacy at follow-up, an education plan for GPs/patients and a patient engagement discharge kit. The standardized GP discharge letter and treatment algorithm have been selected as the highest priority solutions for development.

Conclusion: These initiatives have the potential to improve adherence to guidelines and patient management after ACS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106658PMC
http://dx.doi.org/10.1002/clc.23988DOI Listing

Publication Analysis

Top Keywords

discharge letter
12
lipid management
8
management acs
8
acs europath
8
europath iii
8
ldl-c management
8
management post-acs
8
post-acs patients
8
acute phase
8
areas improvement
8

Similar Publications

Author response to "ED discharge instructions: moving beyond English and French".

CJEM

January 2025

Department of Pediatrics, Cumming School of Medicine, University of Calgary, 2500 University Dr NW, Calgary, AB, T2N 1N4, Canada.

View Article and Find Full Text PDF

ED discharge instructions: moving beyond English and French.

CJEM

January 2025

Department of Emergency Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

View Article and Find Full Text PDF

Introduction: Although maintenance treatment is recommended for the prevention of relapse, in real-world settings, a subset of patients discontinue antipsychotics while having a good prognosis. The prediction of functional remission in patients with schizophrenia after antipsychotic discontinuation (FURSAD) study aims to obtain real-world knowledge regarding the characteristics of schizophrenia (SCZ) patients who achieve functional remission after antipsychotic discontinuation for 1 year or more. This study also aims to establish a prediction model to identify patients likely to benefit from antipsychotic discontinuation.

View Article and Find Full Text PDF

Background: Little is known about how younger and older hospitalized patients differ with respect to reasons for admission, comorbidities, diagnostics, treatment and intercurrent problems.

Objective: The aim of the study was to compare the previously named characteristics in the clinical profile of patients > 90 years old (nonagenarians) with a control group of patients 70-75 years old admitted to an emergency hospital department for internal medicine and cardiology.

Material And Method: The study included all consecutive nonagenarians and gender-matched control patients who were admitted during 2011.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!